Clinical Trial Update: QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for QuitAdvisorMD, a point-of-care tool for brief smoking cessation interventions (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• QuitAdvisorMD

Snippet

Sponsor: Silverchair Science & Communications, LLC | Conditions: Smoking, Tobacco Use Disorder | Phase 2 | Status: UNKNOWN